Omeprazole
HELICID contains the active substance omeprazole. It belongs to a group of medicines called 'proton pump inhibitors'. They work by reducing the amount of acid that the stomach produces.
This medicine can be used as an alternative to oral treatment.
Do not use HELICID if any of the above applies to you. If you are not sure, talk to your doctor, pharmacist, or nurse before using HELICID.
Before starting treatment with HELICID, tell your doctor, pharmacist, or nurse:
HELICID may cause severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms (DRESS) and acute generalized exanthematous pustulosis (AGEP). If you notice any of the following symptoms, stop using HELICID and contact your doctor immediately: severe skin rash, blistering of the skin, eyes, mouth or genitals, high fever.
HELICID may mask the symptoms of other diseases. Therefore, if you get any of the following symptoms, you should contact your doctor immediately:
unintentional weight loss, difficulty swallowing.
stomach pain or indigestion.
vomiting blood or black tarry stools.
severe or persistent diarrhea, as omeprazole has been associated with a small increase in infectious diarrhea.
During treatment with omeprazole, kidney inflammation (interstitial nephritis) may occur. Symptoms such as decreased urine output or blood in the urine and (or) signs of allergy such as fever, rash, and joint pain may occur. If you get any of these symptoms, you should contact your doctor.
When taking a proton pump inhibitor like HELICID, especially over a period of more than one year, there may be a slightly increased risk of fractures of the hip, wrist, or spine. Tell your doctor if you have osteoporosis or are taking medicines called corticosteroids (which can increase the risk of osteoporosis).
If you get a rash on your skin, especially in areas exposed to the sun, you should contact your doctor as soon as possible as you may need to stop your treatment with HELICID. Also, tell your doctor if you get any other side effects, such as joint pain.
Do not give this medicine to children and adolescents under 18 years of age. Experience with the use of HELICID for intravenous administration in children is limited.
Tell your doctor, pharmacist, or nurse about all the medicines you are taking or have recently taken, including those you have bought without a prescription. This includes:
Ketoconazole, itraconazole, posaconazole, or voriconazole (used to treat fungal infections).
If your doctor has prescribed antibiotics amoxicillin and clarithromycin with HELICID to treat ulcers caused by Helicobacter pylori infection, it is very important that you tell your doctor about any other medicines you are taking.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor, pharmacist, or nurse for advice before taking this medicine.
Omeprazole passes into breast milk but it is unlikely to affect the baby when used in the recommended doses. Your doctor will decide whether you can take HELICID while breastfeeding.
It is unlikely that this medicine will affect your ability to drive or use machines. However, side effects such as dizziness and blurred vision (see section 4) may occur. Do not drive or use machines if you are affected by these side effects.
This medicine contains less than 1 mmol sodium (23 mg) per vial, i.e. essentially 'sodium-free'.
If you think you have received too much HELICID, contact your doctor immediately.
If you have any further questions on the use of this product, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Do not delay
Other side effects include:
Common side effects:(may affect up to 1 in 10 people)
Uncommon side effects:(may affect up to 1 in 100 people)
Rare side effects:(may affect up to 1 in 1,000 people)
Very rare side effects:(may affect up to 1 in 10,000 people)
Frequency not known:(frequency cannot be estimated from the available data)
In very rare cases, patients taking omeprazole intravenously, especially in high doses, have reported irreversible vision loss. However, it is not known if this is related to the use of omeprazole.
In very rare cases, HELICID may affect the number of white blood cells, leading to immunodeficiency. If you have an infection with symptoms such as fever and a serious deterioration in general health or fever with local signs of infection such as sore throat/pharynx/mouth or urinary problems, you should contact your doctor as soon as possible to rule out a lack of white blood cells (agranulocytosis) by a blood test. It is important that you inform your doctor that you are taking HELICID.
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in the "Further information" section below.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the vial and carton after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Store in the original package to protect from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
HELICID is a white or almost white, porous, and uniform lyophilized powder.
HELICID 40 mg powder for solution for infusion (powder for infusion) is supplied in a vial. Before administration, the dry powder in the vial is reconstituted to form a solution.
Pack sizes: Vials 1 x 40 mg, 5 x 40 mg, 10 x 40 mg, and 50 x 40 mg.
Not all pack sizes may be marketed.
Zentiva, k.s.
U kabelovny 130,
Dolní Měcholupy
102 37 Prague 10, Czech Republic
Laboratorios Normon, S.A.
Ronda de Valdecarrizo, 6
28760 Tres Cantos
Madrid, Spain
Czech Republic: Omeprazol Zentiva
Bulgaria: Helicid 40 INF powder for solution for infusion 40 mg
Italy: Omeprazol Zentiva Srl
Poland: HELICID
Romania: Omeprazol Zentiva 40 mg pulbere pentru soluţie perfuzabilă
Slovakia: Omeprazole Zentiva
Zentiva Polska Sp. z o.o.,
ul. Bonifraterska 17
Date of last revision of the leaflet: May 2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.